JCRB1332 NALL-1
Cell information
Cell type:general cells (View Pricing Information)
JCRB No. | JCRB1332 | Cell Name | NALL-1 |
---|---|---|---|
Profile | Human 'null' cell from ALL cell line. | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | M | Age | 14 |
Identity | available | Tissue for Primary Cancer | hemo-lymphocytic |
Case history | Acute lymphocytic leukemia (ALL) | Metastasis | |
Tissue Metastasized | Genetics | EB virus was not detected. The cell line lacks both T-cell and B-cell markers. | |
Life Span | infinite | Crisis PDL | |
Morphology | lymphoblast | Character | The cell line is negative for E-rosettes and surface immunoglobulin. |
Classify | tumor | Established by | Hiraki,S. |
Registered by | Miyoshi,I. | Regulation for Distribution | Distribution to commercial companies should be informed to Dr. Miyoshi. |
Comment | Year | 2007 | |
Medium | RPMI 1640 medium with 20% fetal calf serum | Methods for Passages | Subculture every 5-7 days. Dilution. |
Cell Number on Passage | Race | ||
CO2 Conc. | 5% | Tissue Sampling | peripheral blood |
Tissue Type | leukemic lymphoblasts |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Reference | |
---|---|
Pubmed id:200333 | Human leukemic "null" cell line (NALL-1). Hiraki S,Miyoshi I,Kubonishi I,Matsuda Y,Nakayama T,Kishimoto H,Masuji H Cancer. 1977 Nov;40(5):2131-5 |
Pubmed id:197412 | Human B cell, T cell and null cell leukaemic cell lines derived from acute lymphoblastic leukaemias. Miyoshi I,Hiraki S,Tsubota T,Kubonishi I,Matsuda Y,Nakayama T,Kishimoto H,Kimura I,Masuji H Nature. 1977 Jun 30;267(5614):843-4 |
Images |
---|
LOT Information
Cell No. | JCRB1332 | Cell Name | |
---|---|---|---|
LOT No. | 04152011 | Lot Specification | distribution |
Medium | RPMI 1640 medium with 10% heat-inactivated fetal bovine serum (GIBCO Cat. # 10099) | Temperature | 37 C |
Cell Density at Seeding | 5.4 - 6.0 x 10^5 cells/mL | Methods for Passages | Simple dilution, passage every 3-4 days. |
Doubling Time | approx. 44 hrs. | Cell Number in Vial (cells/1ml) | 3.6 x 10^6 |
Viability at cell freezing (%) | 94.2 | Antibiotics Used | free |
Passage Number | Unknown (8 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | No | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPM I1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB1332 | Cell Name | NALL-1 |
---|---|---|---|
LOT No. | 03272009 | Lot Specification | distribution |
Medium | RPMI1640 medium(GIBCO) with 10% heat inactivated fetal bovine serum(Hyclone GRD0051) | Temperature | 37 C |
Cell Density at Seeding | 4.3x10^5 cells/ml | Methods for Passages | split 1/2-1/13 |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 3.8x10^6 |
Viability at cell freezing (%) | 94.3 | Antibiotics Used | free |
Passage Number | p4* | PDL | NT |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NT |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | |
Adhesion | No | Exoteric Gene | NT |
Medium for Freezing | Cell Banker BLC-1(Nihon Zenyaku Industries) | CO2 Conc. | 5 % |
Viability immediately after thawing (%) | Additional information |
Images |
---|